Once-weekly dual receptor agonist (GLP-1, GIP) for glucose control and weight loss, marketed as Mounjaro and Zepbound.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 2.5 mg draws to |
|---|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL | 25 units |
| 10 mg | 1 mL | 10 mg/mL | 25 units |
| 15 mg | 1.5 mL | 10 mg/mL | 25 units |
| 20 mg | 2 mL | 10 mg/mL | 25 units |
| 30 mg | 3 mL | 10 mg/mL | 25 units |
| 40 mg | 4 mL | 10 mg/mL | 25 units |
| 60 mg | 6 mL | 10 mg/mL | 25 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 2.5 mg. At 10 mg/mL, that draws to 25 units on a U-100 insulin syringe.
Dual agonism at the GLP-1 and GIP receptors regulates glucose and suppresses appetite, slowing gastric emptying and enhancing insulin response.
Tirzepatide is commonly taken in the morning.
Add 0.5 mL of bacteriostatic water to a 5 mg Tirzepatide vial for a 10 mg/mL solution.
A common Tirzepatide starting dose is 2.5 mg, which at 10 mg/mL draws to 25 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the Tirzepatide vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.
Add 0.5 mL of bacteriostatic water to a 5 mg Tirzepatide vial for a 10 mg/mL solution. A 2.5 mg dose then draws to 25 units on a U-100 insulin syringe.
Add 1 mL of bacteriostatic water to a 10 mg Tirzepatide vial for a 10 mg/mL solution. A 2.5 mg dose then draws to 25 units on a U-100 insulin syringe.
Add 1.5 mL of bacteriostatic water to a 15 mg Tirzepatide vial for a 10 mg/mL solution. A 2.5 mg dose then draws to 25 units on a U-100 insulin syringe.
Add 2 mL of bacteriostatic water to a 20 mg Tirzepatide vial for a 10 mg/mL solution. A 2.5 mg dose then draws to 25 units on a U-100 insulin syringe.
Add 3 mL of bacteriostatic water to a 30 mg Tirzepatide vial for a 10 mg/mL solution. A 2.5 mg dose then draws to 25 units on a U-100 insulin syringe.
Add 4 mL of bacteriostatic water to a 40 mg Tirzepatide vial for a 10 mg/mL solution. A 2.5 mg dose then draws to 25 units on a U-100 insulin syringe.
Add 6 mL of bacteriostatic water to a 60 mg Tirzepatide vial for a 10 mg/mL solution. A 2.5 mg dose then draws to 25 units on a U-100 insulin syringe.